📰 Extension Study News
Page 2 - Extension Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Extension Study. Real-time updates on events, politics, business and more.
February 2, 2023
- Suprachoroidal CLS-AX Resulted in Favorable Safety Data, Durability and Biologic Effect Over 6 Months in Treatment-Experienced Anti-VEGF Sub-Responders -...
May 13, 2022
/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the U.S. Food and Drug Administration (FDA) has approved RADICAVA ORS®...
January 10, 2022
SINGAPORE, Jan. 10, 2022 /PRNewswire/ -- GlaxoSmithKline (GSK) Singapore announced that a new vaccine to help protect against shingles, Shingrix, is now available in Singapore. Shingrix is a non-live, recombinant subunit adjuvanted vaccine, given intramuscularly in two doses, for the prevention of shingles (herpes zoster). The vaccine was initially approved for adults aged 50 years and over, with the...
October 13, 2021
Investegate announcements from Sanofi, New long-term data reinforcing promising safety and efficacy profile of brain-penetrant tolebrutinib presented at ECTRIMS 2021 
October 13, 2021
New long-term data reinforcing promising safety and efficacy profile of brain-penetrant tolebrutinib presented at ECTRIMS 2021 One-year results from Phase 2b extension study of brain-penetrant tolebrutinib
May 30, 2021
Governor Larry Hogan announced in letters to General Assembly leaders that, in accordance with Article II, Section 17 of the Maryland Constitution, he has vetoed the following legislation passed during the 2021 legislative session:
May 23, 2021
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced efficacy and safety data for STELARA® (ustekinumab) in Crohns...
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) ...